SIMPSON LAB

Danny Simpson.jpg

The research focus of the Simpson Lab is on the use of non-invasive bioimaging markers in oncology and incorporation of novel imaging modalities into radiation treatment planning. A primary research project is designed to evaluate the diagnostic accuracy of restricted spectrum imaging (RSI), a novel MRI diffusion technique, for presurgical assessment of treatment response in patients undergoing neoadjuvant radiation therapy for rectal cancer. As the principal investigator of this project, Dr. Simpson has assembled a multi-disciplinary investigative team with expertise in diagnostic radiology, colorectal surgery, radiation oncology, medical oncology, and pathology. 

cellularity.png
therectum-wide.jpg

 The ultimate goal of this research is to improve our understanding of in vivo tumor responses and to help to direct cancer therapy at an individual level.